OBJECTIVE To explore the adjustment of antiviral programs for HBeAg-positive chronic hepatitis B(CHB)patients treated with pegylated interferons(PEG-IFN)and observed the clinical effects so as to provide guidance for clinical treatment.METHODS A total of 98 HBeAg-positive CHB patients who were treated with PEG-IFN from Jul 2006 to Aug 2015 were retrospectively analyzed,the enrolled patients were grouped according to the adjustment and time of the antiviral programs and time of interferon therapy.The number ...